Publication Name	World Journal of Gastroenterology
Manuscript ID	3436
Country	Italy

Received	2013-05-01 12:03
Peer-Review Started	2013-05-02 16:09
To Make the First Decision	2013-05-28 12:05
Return for Revision	2013-06-13 11:59
Revised	2013-06-14 20:24
Second Decision	2013-07-05 11:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-07-05 13:01
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-08-22 14:29
Publish the Manuscript Online	2013-09-14 11:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis
Manuscript Source	Invited Manuscript
All Author List	Carlo Calabrese, Chiara Praticò, Andrea Calafiore, Maurizio Coscia, Lorenzo Gentilini, Gilberto Poggioli, Paolo Gionchetti, Massimo Campieri and Fernando Rizzello
Funding Agency and Grant Number
Corresponding Author	Carlo Calabrese, MD, PhD, DIMEC, Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. carlo.calabrese2@unibo.it
Key Words	Familial adenomatous polyposis; Ileal pouch-anal anastomosis; Duodenal polyps; Eviendep
Core Tip	Our open study demonstrated for the first time that short-term (90 d) supplementation with Eviendep? in familial adenomatous polyposis patients with ileal pouch-anal anastomosis and with recurrent adenomas in the duodenal mucosa, resulted effective in reducing polyps number of 32% and size of 51%. Eviendep? was easy to manage and its daily use was well tolerated by the patients. Its safety was guaranteed by its composition. Each ingredient is blended into the composition in a lower dose than the one otherwise needed for the single component to similarly exert the desired effect, thus leading to synergistic and/or potentiating effect, with the added advantage of higher safety, even over long-term exposure.
Publish Date	2013-09-14 11:17
Citation	Calabrese C, Praticò C, Calafiore A, Coscia M, Gentilini L, Poggioli G, Gionchetti P, Campieri M, Rizzello F. Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. World J Gastroenterol 2013; 19(34): 5671-5677
URL	http://www.wjgnet.com/1007-9327/full/v19/i34/5671.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i34.5671

Full Article (PDF)	WJG-19-5671.pdf
Manuscript File	3436-Review.docx
Answering Reviewers	3436-Answering reviewers.pdf
Copyright License Agreement	3436-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	3436-Language certificate.pdf
Peer-review Report	3436-Peer reviews.pdf
Scientific Editor Work List	3436-Scientific editor work list.doc